Effect of safety measures on bacterial contamination rates of blood components in Germany

Transfusion Medicine and Hemotherapy

Volumn 38, Issue 4, 2011, Pages 231-235

  Walther Wenke, Gabriele ^a,g   Däubener, Walter ^b   Heiden, Margarethe ^c   Hoch, Jochen ^d   Hornei, Britt ^e   Volkers, Peter ^c   Von König, Carl Heinz Wirsing ^f  

^a Zentrum für Transfusionsmedizin Münster   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c PAUL EHRLICH INSTITUT   (Germany)

^d UNIVERSITY HOSPITAL BONN   (Germany)

^e SYNLAB ACADEMY   (Germany)

^f HELIOS KLINIKUM KREFELD   (Germany)

^g DRK Blutspendedienst West   (Germany)

Author keywords

Bacterial contamination; Blood components; Contamination rate; Quality control

Indexed keywords

THROMBOCYTE CONCENTRATE;

BACTERIUM CONTAMINATION; BACTERIUM CULTURE; BLOOD COMPONENT; BLOOD DONOR; ERYTHROCYTE; GERMANY; LEUKOCYTE; NONHUMAN; REVIEW;

EID: 80052196816     PISSN: 16603796     EISSN: 16603818     Source Type: Journal    
DOI: 10.1159/000330417     Document Type: Review

References (35)

1. Walther-Wenke G, Doerner R, Montag-Lessing T, Lange H, B, Daeubener W, et al: Bacterial contamination of blood components: results of a two-year survey in Germany (abstract). Transfusion 1999;39 (suppl 1):22.
2. Arbeitskreis Blut: Mindestanforderungen zur Sterilitätstestung von Blutkomponenten. 23. Sitzung des Arbeitskreises Blut am 05.06.1997. Bundesgesundheitsblatt 1997;8:307-309.
3. Arbeitskreis Blut: Herstellung kontaminationssicherer Schlauchverbindungen bei Blutbeuteln. 31. Sitzung des Arbeitskreises Blut am 02.12.1998. Bundesgesundheitsblatt 1998;41:2.
4. Bundesärztekammer, Paul-Ehrlich-Institut: Richtlinien zur Gewinnung von Blut und Blutbestandteilen und zur Anwendung von Blutprodukten (Hämotherapie) Gesamtnovelle 2005 mit Richtlinienanpassung 2010. Köln, Deutscher Ärzteverlag, 2010.
5. Arbeitskreis Blut: Zusätzliche Risikovorsorge bei Blutspenden: Beschleunigte Einführung der Leukozytendepletion und Spenderausschluss bei mehr als sechsmonatigem Aufenthalt im Vereinigten Königreich. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 2001;44:110-111.
6. Arbeitskreis Blut: Einführung des Predonation Samplings. 48. Sitzung des Arbeitskreises Blut am 26.06,2002. Bundesgesundheitsblatt 2002;45:756 (English version: www.rki.de).
7. Walther-Wenke G, Doerner R, Montag T, et al: Bacterial contamination of platelet concentrates prepared by different methods: results of standardized sterility testing in Germany: Vox Sang 2006; 90:177-182.
8. Walther-Wenke G, Wirsing von König CH, Daeubener W, et al: Monitoring bacterial contamination of blood components in Germany: effect of contamination reduction measures. Vox Sang 2011; 100:356-366.
9. De Korte D, Curvers J, de Kort WLAM, et al: Effects of skin disinfection method, deviation bag, and bacterial screening on clinical safety of platelet transfusions in the Netherlands. Transfusion 2006; 46:476-485. (Pubitemid 43334104)
10. Mc Donald CP: Bacterial risk reduction by improved donor arm disinfection, diversion and bacterial screening. Transfus Med 2006;16:381-396. (Pubitemid 44813848)
11. Benjamin RF, Kline L, Dy BA, et al: Bacterial contamination of whole blood-derived platelets: the introduction of sample diversion and prestorage pooling with culture testing in the American Red Cross. Transfusion 2008;48:2348-2355.
12. International Forum: Detection of bacterial contamination of platelet concentrates. Vox Sang 2007; 93:260-277.
13. Te Boekhorst PAW, Beckers EAM, Vos MC, et al: Clinical significance of bacteriologic screening in platelet concentrates. Transfusion 2005;45:514-519.
14. Larsen CP, Ezligini F, Hermansen NO, et al: Six years' experience of using the BacT/ALERT system to screen all platelet concentrates, and additional testing of outdated platelet concentrates to estimate the frequency of false-negative results. Vox Sang 2005;88:93-97. (Pubitemid 40362924)
15. Ramírez-Arcos S, Jenkins C, Dion J, et al: Canadian experience with detection of bacterial contamination in apheresis platelets. Transfusion 2007; 47:421-429.
16. Eder AF, Kennedy JM, Dy BA, et al: Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004-2006). Transfusion 2007;47:1134-1142. (Pubitemid 46934307)
17. Benjamin RJ, Wagner SJ: The residual risk of sepsis: modelling the effect of concentration on bacterial detection in two-bottle culture systems and on estimation of false-negative culture rates. Transfusion 2007;47:1381-1389. (Pubitemid 47101084)
18. Dumont LJ, Kleinmann S, Murphy JR, et al: Screening of single-donor apheresis platelets for bacterial contamination: the PASSPORT study results. Transfusion 2010;50:589-599.
19. Schrezenmeier H, Walther-Wenke G, Müller TH, et al: Bacterial contamination of platelet concentrates: results of a prospective multicenter study comparing pooled whole blood-derived platelets and apheresis platelets. Transfusion 2007;47:644-652. (Pubitemid 46449625)
20. Murphy WG, Foley M, Doherty C, et al: Screening platelet concentrates for bacterial contamination: low numbers of bacteria and slow growth in contaminated units mandate an alternative approach to product safety. Vox Sang 2008;95:13-19. (Pubitemid 351799415)
21. Pearce S, Rowe GP, Field SP: Screening of platelets for bacterial contamination at the Welsh Blood Service. Transfus Med 2011;21:25-32.
22. International Forum: Evaluation of stored platelets. Vox Sang 2004;86:203-223.
23. Högmann CF, Engstrand L: Factors affecting growth of Yersinia enterocolitica in cellular blood products. Transfus Med Rev 1996;10:259-275. (Pubitemid 26354135)
24. Högman CF, Gong J, Erisksson I, et al: White cells protect donor blood against bacterial contamination. Transfusion 1991;31:620-626.
25. Siblini L, Lafeuillade B, Ros A, et al: Influence of blood storage conditions and white blood cell filtration on the bacterial load of blood deliberately inoculated with Gram-positive and Gram-negative pathogens. Vox Sang 2004:87:241-249. (Pubitemid 39627151)
26. Buchholz DH, AuBuchon JP, Snyder EL, et al: Effects of white cell reduction on the resistance of blood components to bacterial multiplication. Transfusion 1994;34:852-857. (Pubitemid 24308105)
27. Wagner SJ, Robinette D, Friedman LI, et al: Diversion of initial blood flow to prevent wholeblood contamination by skin surface bacteria: an in vitro model. Transfusion 2000:40:335-338. (Pubitemid 30171685)
28. Bruneau C, Perez P, Chassaigne M, et al: Efficacy of a new collection procedure for preventing bacterial contamination of whole blood donations. Transfusion 2001;41:74-81. (Pubitemid 32142249)
29. De Korte D, Marcelis JH, Verhoeven AJ, et al: Diversion of first blood volume results in a reduction of bacterial contamination for whole-blood collections. Vox Sang 2002;83:13-16. (Pubitemid 36806493)
30. McDonald CP, Roy A, Mahajan P, et al: Relative values of the interventions of díversion and improved donor-arm disinfection to reduce the bacterial risk from blood transfusion. Vox Sang 2004;86:178-182. (Pubitemid 38529507)
31. Wagner SJ, Friedman LI, Dodd RY: Transfusionassociated bacterial sepsis. Clin Microbiol Rev 1994;7:290-302.
32. Casewell MW, Slater NG, Cooper JE: Operatin theatre water-baths as a cause of Pseudomonas septicaemia. J Hosp Infect 1981;2:237-247.
33. Muyldermans G, de Smet F, Pierard D: Neonatal infections with Pseudomonas aeruginosa associated with a water-bath used to thaw fresh frozen plasma. J. Hosp Infect 1998;39:309-314. (Pubitemid 28393657)
34. Hillyer CD, Josephson CD, Blajchman MA, Vostal JG, Epstein JS, Goodman JL: Bacterial contamination of blood components: risks, strategies, and regulation: joint ASH and AABB educational session in transfusion medicine. Hematology Am Soc Hematol Educ Program 2003:575-589.
35. Jacobs MR, Caryn EG, Lazarus HM, Yomtovian RA: Relationsship between bacterial load, species, virulence, and transfusion reaction with transfusion of bacterially contaminated platelets. Clin Infect Dis 2008;1214-1220. (Pubitemid 351589905)